Targeted medications are the generic name, and eugenol is the generic name for levothyroxine sodium tablets. Taking targeted drugs and levothyroxine sodium tablets is not recommended for New Crown vaccination. Targeted drugs are one of the commonly used drugs for the treatment of malignant tumors, and vaccination with New Crown Pneumonia Vaccine is not recommended for patients with malignant tumors who are taking targeted drugs. Because patients who are being treated with targeted drugs generally indicate that the condition of the tumor is not stable, and the possibility that the tumor is developing cannot be ruled out. If the new crown pneumonia vaccine is inoculated, it is not ruled out that it will increase the probability of adverse drug reactions, and it is also not ruled out that it is easy to cause abnormal immune reactions. The prerequisite for vaccination with levothyroxine sodium tablets is that the thyroid function of patients with hypothyroidism who are taking the drug orally should be within the normal range and there are no other contraindications to the administration of the new crown vaccine. New Crown vaccine is not recommended if you are allergic to the components of the vaccine, or if you suffer from a serious chronic disease, or are in the active phase of the disease, fever, acute infections. Therefore, for safety reasons, people with malignant tumors who take targeted drugs and people taking levothyroxine sodium tablets are advised not to get the New Crown vaccine. If one’s condition is stable and one is willing to receive the new crown vaccine, it is recommended that one consults the treating physician first, who will make a comprehensive judgment as to whether the vaccine can be administered according to the specific circumstances. Tip: In this article, “new coronavirus pneumonia” and “new coronavirus pneumonia” were renamed to “new coronavirus infection” on December 26, 2022, as announced by the National Health Commission.